Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
Bryan A Faller, Barbara BurtnessDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAAbstract: Pancreatic adenocarcinoma is a common malignancy that remains refractory to available therapies. Gemcitabine has long been the standard, first-line agent in advanced disease. The e...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2009-09-01
|
| סדרה: | Biologics: Targets & Therapy |
| גישה מקוונת: | http://www.dovepress.com/treatment-of-pancreatic-cancer-with-epidermal-growth-factor-receptor-t-a3546 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|